Robert Iannone has been Jazz’s EVP, Research and Development since May 2019. Dr. Iannone oversees product development, clinical operations and regulatory affairs. Dr. Iannone brings more than 16 years of experience in clinical drug development, having worked on immuno-oncology programs at AstraZeneca and its biologics arm MedImmune. He completed his residency in Pediatrics and fellowship in Pediatric Hematology‐Oncology at Johns Hopkins University.